Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Charmian Proskauer
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
[[File:Charmian Proskauer.png|thumb|right|Source: www.prohealth.com]] '''Charmian Proskauer''' is the President of the [[Massachusetts CFIDS/ME & FM Association]], one of the oldest and most active [[ME/CFS]] patient organizations. Previous to her term as president, she served as Website Manager for the association.<ref>https://www.linkedin.com/in/charmian-proskauer-4540352</ref><ref>https://www.masscfids.org/newsletters/646-advocacy-what-s-happening</ref> She was a consultant for the [[CFSAC]] Workgroup on the [[Institute of Medicine report]] and [[Pathways to prevention report]]<ref>http://www.hhs.gov/advcomcfs/meetings/minutes/cfsac-jan15-2015-meeting-minutes.pdf</ref> and frequently gives testimony to the CFSAC committee. She is the Chair of the [[US Action Working Group]], a group of American organizations and activists involve in advocacy. In March 2016, Proskauer, along with other activists, visited Congressional staff members to increase awareness of the illness and the need for increased funding.<ref>http://solvecfs.org/Carol+Head+Meets+with+NIH+Congressional+Staff</ref><ref>https://www.masscfids.org/newsletters/646-advocacy-what-s-happening</ref> Initially, Proskauer was against the [[Pathways to prevention report]] (P2P) process, stating in June 2014: "This appears to be a closed process within [[NIH]], which over many years has given little serious attention to this very serious illness...I therefore urge that the P2P process be suspended."<ref>http://www.hhs.gov/advcomcfs/meetings/presentations/0614-charmian-proskauer.pdf</ref> After the P2P report was released, she advised the CFSAC committee as a Workgroup Member of the IOM/P2P Workgroup for CFSAC in 2015, where she "supported the recommendations of the CFSAC P2P and IOM workgroups" and "expressed hope that the workgroup process can be a model for working together in the future to achieve earlier diagnosis and better treatment for patients."<ref>http://www.hhs.gov/advcomcfs/meetings/minutes/cfsac-aug19-2015-meeting-minutes.html#%20IOM/P2P%20Workgroup%20Report%20and%20Recommendations</ref> One of the areas in which she advocates increased resources and research is in the newly ill, maintaining that since it can take years before a patient is correctly diagnosed, little research is done on how the disease progresses in the initial stage of onset.<ref>http://www.hhs.gov/advcomcfs/meetings/minutes/cfsac-aug19-2015-meeting-minutes.html#%20IOM/P2P%20Workgroup%20Report%20and%20Recommendations</ref> ==HHS/CFSAC meetings== *Jun 16,17, 2014 [http://www.hhs.gov/advcomcfs/meetings/presentations/0614-charmian-proskauer.pdf Proskauer's Public Comments for the June 16-17, 2014 meeting] *Jan 2015 [http://www.hhs.gov/advcomcfs/recommendations/cfsac-pathways-to-prevention-january-2015-updated.pdf Comments from CFSAC on the Draft Report to Pathways to Prevention: Advancing the Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome to which Proskauer provided contributions to the document] *Aug 19, 2015 [http://www.hhs.gov/advcomcfs/meetings/minutes/cfsac-aug19-2015-meeting-minutes.html#%20Committee%20Discussion%20-%20Patient%20Registry%20Report%20and%20Recommendations CFSAC 8/19 Meeting Minutes including discussion from IOM/P2P Workgroup Report and Recommendations as well as public comment from Proskauer] ==Talks and interviews== *Jan 2014, [https://www.youtube.com/watch?v=gghbnL0ww0o Presentation to the Institute of Medicine Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome regarding children and adolescent patients] [https://www.masscfids.org/advocacy/503-remarks-to-the-institute-of-medicine-committee Text for video] *Mar 29, 2017, [https://www.youtube.com/watch?v=cOEed2Gu-l4 [[ME/CFS Alert]] Episode 86 - The work of the Massachusetts CFIDS/ME & FM Association with Charmian Proskauer] ==Research studies== *2019, Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning<ref>{{Cite journal | last = Proskauer | first = Charmian | authorlink = Charmian Proskauer | last2 = Rowe | first2 = Peter C. | author-link2 = Peter Rowe | last3 = Lapp | first3 = Charles W. | author-link3 = Charles Lapp | last4 = DeMaria | first4 = Alfred Jr | author-link4 = | last5 = Bateman | first5 = Lucinda | author-link5 = Lucinda Bateman | last6 = Attewell | first6 = John R. | last7 = Proskauer | first7 = Daniel | last8 = Kiernicki | first8 = David J. | last9 = Adebayo | first9 = Seyi | date = 2019 | title=Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning | url =https://www.frontiersin.org/articles/10.3389/fped.2018.00412/full | journal = Frontiers in Pediatrics|language=English | volume = 6 | issue = | pages = |doi=10.3389/fped.2018.00412|issn=2296-2360|pmc=|pmid=30671425|quote=|via=}}</ref> [https://www.frontiersin.org/articles/10.3389/fped.2018.00412/full (Full text)] ==References== {{Reflist}} [[Category:Advocates or allies]] [[Category:American advocates or allies]]
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Templates used on this page:
Template:Cite journal
(
edit
)
Template:Main other
(
edit
)
Template:Reflist
(
edit
)
Module:Check for unknown parameters
(
edit
)
Module:Citation/CS1
(
edit
)
Module:Citation/CS1/COinS
(
edit
)
Module:Citation/CS1/Configuration
(
edit
)
Module:Citation/CS1/Date validation
(
edit
)
Module:Citation/CS1/Identifiers
(
edit
)
Module:Citation/CS1/Utilities
(
edit
)
Module:Citation/CS1/Whitelist
(
edit
)
Module:No globals
(
edit
)
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs